Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst

William Blair starts Natera coverage, citing MRD growth potential, strong moat, and diversified pipeline supporting long-term outlook.

Latest Ratings for NTRA

DateFirmActionFromTo Mar 2022Goldman SachsInitiates Coverage OnBuy Feb 2022Morgan StanleyMaintainsOverweight Feb 2022BairdMaintainsOutperform

View More Analyst Ratings for NTRA

View the Latest Analyst Ratings

Importance Rank: 
1

read more